Health & Wellness

⚔Coronavirus Vaccine by Oxford: Serum Institute of India to Start Licensure Trials, Manufacturing of AZD1222 Soon

By Team Latestly

Adar Poonawalla, CEO of SII, said the institute will apply for the licensure trials of the AstraZeneca-Oxford-made COVID-19 vaccine in a week's time.

Read Full Story
Read All QuickLY